COVID-19 Update: Biogen is committed to continuing to provide support for our patients during these unprecedented times. Biogen Support Services is here to help your patients get started on treatment and provide additional support throughout their time on a Biogen therapy. Should you need help in finding an alternative infusion site for your patients, including the temporary option of in-home infusion, please contact Biogen Patient Services at 1-800-456-2255. For information about Biogen initiatives in response to the COVID-19 outbreak please visitBiogen COVID-19 Information Center.
83%of patients taking TYSABRI had no sustained physical disability progression for 12 weeks vs 71% with placebo (primary endpoint: percentage with sustained increase in disability was 17% vs 29%; p<0.001)1,2